A detailed history of Mv Capital Management, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Mv Capital Management, Inc. holds 818 shares of BSX stock, worth $83,141. This represents 0.01% of its overall portfolio holdings.

Number of Shares
818
Previous 814 0.49%
Holding current value
$83,141
Previous $62,000 9.68%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$72.96 - $84.0 $291 - $336
4 Added 0.49%
818 $68,000
Q2 2024

Aug 01, 2024

BUY
$67.33 - $77.71 $6,463 - $7,460
96 Added 13.37%
814 $62,000
Q1 2024

Apr 18, 2024

BUY
$57.6 - $68.62 $748 - $892
13 Added 1.84%
718 $49,000
Q4 2023

Jan 29, 2024

BUY
$48.64 - $57.81 $3,307 - $3,931
68 Added 10.68%
705 $40,000
Q3 2023

Nov 07, 2023

BUY
$50.19 - $54.68 $1,756 - $1,913
35 Added 5.81%
637 $33,000
Q2 2023

Aug 03, 2023

BUY
$49.72 - $54.64 $2,784 - $3,059
56 Added 10.26%
602 $32,000
Q1 2023

Apr 26, 2023

BUY
$45.09 - $50.03 $6,538 - $7,254
145 Added 36.16%
546 $27,000
Q4 2022

Jan 27, 2023

BUY
$39.56 - $47.22 $4,232 - $5,052
107 Added 36.39%
401 $0
Q3 2022

Oct 24, 2022

BUY
$36.71 - $109.66 $5,396 - $16,120
147 Added 100.0%
294 $11,000
Q2 2022

Jul 19, 2022

SELL
$35.24 - $47.1 $11,593 - $15,495
-329 Reduced 69.12%
147 $5,000
Q1 2022

May 09, 2022

BUY
$40.9 - $45.1 $8,589 - $9,471
210 Added 78.95%
476 $21,000
Q4 2021

Feb 02, 2022

SELL
$38.07 - $44.87 $6,015 - $7,089
-158 Reduced 37.26%
266 $11,000
Q3 2021

Nov 12, 2021

BUY
$41.23 - $45.88 $8,575 - $9,543
208 Added 96.3%
424 $18,000
Q2 2021

Aug 03, 2021

BUY
$38.58 - $44.24 $6,982 - $8,007
181 Added 517.14%
216 $9,000
Q1 2021

May 12, 2021

BUY
$35.27 - $39.67 $1,234 - $1,388
35 New
35 $1,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $146B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Mv Capital Management, Inc. Portfolio

Follow Mv Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mv Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mv Capital Management, Inc. with notifications on news.